Systemic Lupus Erythematosus
📧 Sign up to get email alerts when something new happens for Systemic Lupus Erythematosus.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2015-11-13FDA Approved: MYCOPHENOLATE MOFETIL — Supplemental Application (Strides Pharma Science Limited)
The FDA approved a supplemental application to allow Strides Pharma Science Limited to market a generic mycophenolate mofetil. This approval…
-
FDA approval · 2015-10-30FDA Approved: MYCOPHENOLATE MOFETIL — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for mycophenolate mofetil filed by Mylan Pharmaceuticals Inc. The action relates to the approved gen…
-
CLINICAL_TRIALS trial_result · 2015-10-15Clinical Trial Update: Genetic Study of Lupus Patients and Their Families
A completed genetic study involving lupus patients and their families to identify hereditary factors related to systemic lupus erythematosus…
-
CLINICAL_TRIALS withdrawal · 2015-09-18Clinical Trial Update: The Effect of Milnacipran on Fatigue and Quality of Life in Lupus Patients [Phase 4]
Phase 4 trial evaluating milnacipran for fatigue and quality of life in lupus patients has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2015-09-14Clinical Trial Update: Efficacy and Safety of Simvastatin-ezetimibe Combination Therapy Among Patients With SLE [EARLY_Phase 1]
An early-phase trial update assessing the efficacy and safety of a simvastatin-ezetimibe combination in patients with systemic lupus erythem…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2015-09-10Clinical Trial Update: Levothyroxine in Pregnant SLE Patients [Phase 4]
A Phase 4 clinical trial evaluating levothyroxine in pregnant patients with systemic lupus erythematosus has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2015-09-01Clinical Trial Update: Study of LJP 394 (Abetimus Sodium) in Lupus Patients [Phase 2]
A Phase 2 study of LJP 394 (Abetimus Sodium) in patients with systemic lupus erythematosus has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2015-08-17Clinical Trial Update: Omega 3 Fatty Acids and Systemic Lupus Erythematosus [NA]
This clinical trial update indicates that a study of omega-3 fatty acids for systemic lupus erythematosus has been completed.
-
CLINICAL_TRIALS withdrawal · 2015-08-13Clinical Trial Update: CHABLIS-SC2: A Study of the Efficacy and Safety of Subcutaneous Blisibimod in Subjects With Systemic Lupus Erythematosus With or Without Nephritis [Phase 3]
The CHABLIS-SC2 Phase 3 trial of subcutaneous blisibimod for systemic lupus erythematosus (with or without nephritis) has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2015-08-04Clinical Trial Update: The Efficacy and Safety of Calcitriol for the Treatment of Lupus Nephritis and Persistent Proteinuria [Phase 4]
A Phase 4 clinical trial evaluating calcitriol for systemic lupus erythematosus–associated lupus nephritis with persistent proteinuria has b…
-
CLINICAL_TRIALS trial_result · 2015-08-03Clinical Trial Update: Tacrolimus for the Treatment of Systemic Lupus Erythematosus With Membranous Nephritis [Phase 4]
Phase 4 clinical trial update evaluating tacrolimus for treatment of systemic lupus erythematosus with membranous nephritis.
-
CLINICAL_TRIALS trial_result · 2015-07-16Clinical Trial Update: Safety Study of CDP7657 in Patients With Systemic Lupus Erythematosus [Phase 1]
A Phase 1 safety study of CDP7657 in patients with systemic lupus erythematosus has completed.
-
CLINICAL_TRIALS trial_result · 2015-07-10Clinical Trial Update: Comparison of the Efficacy of Two Rituximab Treatment Regimens in Patients With Lupus Nephropathy [Phase 3]
A Phase 3 trial comparing two rituximab regimens in lupus nephritis has been terminated.
-
FDA approval · 2015-07-09FDA Approved: CELLCEPT — Supplemental Application (Genentech, Inc.)
FDA approved a supplemental application for CellCept (mycophenolate mofetil) submitted by Genentech, Inc.
-
CLINICAL_TRIALS trial_result · 2015-06-25Clinical Trial Update: Exploratory Study of Changes in Disease Activity and Biomarkers With ABR-215757 in Patients With Mild Active Systemic Lupus Erythematosus (SLE) [Phase 2]
This is a Phase 2 exploratory study of ABR-215757 in patients with mild active systemic lupus erythematosus, designed to assess changes in d…
-
CLINICAL_TRIALS trial_result · 2015-06-23Clinical Trial Update: A Trial of Rosuvastatin in Systemic Lupus Erythematosus [Phase 2]
This clinical trial update confirms completion of a Phase 2 study of rosuvastatin in Systemic Lupus Erythematosus. The study also lists athe…
-
CLINICAL_TRIALS research · 2015-06-08Clinical Trial Update: A Pilot-Study With Low-dose hrIL-2 for the Treatment of Systemic Lupus Erythematosus [Phase 2]
A Phase 2 pilot study is evaluating low-dose hrIL-2 for the treatment of Systemic Lupus Erythematosus, with the study status currently unkno…
-
FDA approval · 2015-06-01FDA Approved: MYCOPHENOLATE MOFETIL — Supplemental Application (Accord Healthcare Inc.)
FDA approved a supplemental application for Mycophenolate mofetil from Accord Healthcare Inc., updating the approved generic product.
-
CLINICAL_TRIALS trial_result · 2015-05-14Clinical Trial Update: A Study to Examine the Safety, Pharmacokinetics and Pharmacodynamics of Single Dose of AMG 623 in Subjects With Systemic Lupus Erythematosus [Phase 1]
Phase 1 trial assessing safety, pharmacokinetics, and pharmacodynamics of a single dose of AMG 623 in adults with systemic lupus erythematos…
-
CLINICAL_TRIALS trial_result · 2015-05-12Clinical Trial Update: Study to Compare Properties of Epratuzumab When Given as an Injection Under the Skin or Directly Into the Blood [Phase 1]
Phase 1 study comparing subcutaneous versus intravenous administration of epratuzumab in systemic lupus erythematosus has been completed.
-
CLINICAL_TRIALS trial_result · 2015-04-13Clinical Trial Update: Low-dose IL-2( Interleukin-2) Treatment in SLE [NA]
A completed clinical trial evaluating low-dose interleukin-2 therapy for systemic lupus erythematosus; results posted in 2015.
-
CLINICAL_TRIALS trial_result · 2015-04-08Clinical Trial Update: A Study to Examine the Safety, Pharmacokinetics and Pharmacodynamics of AMG 623 in Subjects With Systemic Lupus Erythematosus [Phase 1]
A Phase 1 study evaluating the safety, pharmacokinetics and pharmacodynamics of AMG 623 in subjects with systemic lupus erythematosus has be…
-
CLINICAL_TRIALS trial_result · 2015-03-30Clinical Trial Update: A Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of AMG 557 in Subjects With Systemic Lupus Erythematosus [Phase 1]
Phase 1 study evaluating the safety, pharmacokinetics and pharmacodynamics of AMG 557 in systemic lupus erythematosus has completed.
-
CLINICAL_TRIALS trial_result · 2015-03-06Clinical Trial Update: Pilot Study of Total Body Irradiation in Combination With Cyclophosphamide, Anti-thymocyte Globulin, and Autologous CD34-Selected Peripheral Blood Stem Cell Transplantation in Children With Refractory Autoimmune Disorders [Phase 1]
Completed Phase 1 pilot study evaluating total body irradiation with cyclophosphamide, anti-thymocyte globulin, and autologous CD34-selected…
-
FDA approval · 2015-01-20FDA Approved: HYDROXYCHLOROQUINE SULFATE — Supplemental Application (Aurobindo Pharma Limited)
The FDA approved a supplemental application for hydroxychloroquine sulfate submitted by Aurobindo Pharma Limited.